Global Infusion Therapy Market

Infusion Therapy Comprehensive Study by Type (Intravenous Set, Needleless Catheter, Infusion Pump), Application (Chemotherapy, Diabetes, Hydration Therapy, Inotropic Therapy, Pain Management, HIV, Post-Transplant Therapies, Total Parenteral Nutrition, Hemophilia, Others), Infusion Pumps (Large Volume Infusion Pumps, Syringe Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Ambulatory Infusion Pumps, Chemotherapy Infusion Pumps, Disposable Infusion Pumps, Enteral Infusion Pumps, Insulin Infusion Pumps, Implantable Infusion Pumps), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Care, Others), Accessories and Consumables (Infusion Sets, I.V Sets, Docking Stations, Needleless Connectors, Pump Reservoirs/Cartridges, Valves and Filters, Wireless Connectivity, Barcode Readers, Infusion Data Management/Analysis Software) Players and Region - Global Market Outlook to 2030

Infusion Therapy Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 10.34%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Infusion Therapy
Due to an increase in the number of people suffering from chronic pain, cancer, and diabetes, the worldwide Infusion Therapy market is likely to see strong demand in the coming year. Oral medication is the least effective pain-relieving treatment approach, with infusion therapy being the most widely employed. The medication is frequently given intravenously or subcutaneously in this treatment. Patients are switching from traditional therapies to specialized infusion therapy treatments since the results are more successful, thanks to technological advancements. Infusion Therapy is used to treat a variety of conditions, including diabetes, gastrointestinal illnesses, cancer, and many others. Administrative services, patient education services, care coordination services, and pharmacy services are all included in infusion therapy. These elements contribute to the global market's expansion.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)
CAGR10.34%


The global market for infusion treatment is fiercely competitive. Key firms used sophisticated healthcare technology to improve healthcare services in order to thrive in a competitive market. Furthermore, large players frequently use methods like mergers, acquisitions, and new product releases to maintain market share and diversify their product portfolio. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Infusion Therapy market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Gentiva Health Services (United States), American Home Patient (United States), Lincare Holdings, Inc. (United States), Apria Healthcare. (United States), ContinuumRx (United States), BioScrip, Inc. (United States), CareCentrix, Inc. (United States), Coram LLC (United States), Medical Services of America, Inc. (United States) and Cleveland Clinic (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Option Care Enterprises, Inc. (United States), Allina Health (United States), ICU Medical, Inc. (United States), Hospira, Inc.(United States), B. Braun Melsungen AG (Germany), Caesarea Medical Electronics (Israel), JMSCo. Ltd., Baxter (United States), Novartis (Switzerland) and Roche Diagnostics (Switzerland).

Segmentation Overview
AMA Research has segmented the market of Global Infusion Therapy market by Type (Intravenous Set, Needleless Catheter and Infusion Pump), Application (Chemotherapy, Diabetes, Hydration Therapy, Inotropic Therapy, Pain Management, HIV, Post-Transplant Therapies, Total Parenteral Nutrition, Hemophilia and Others) and Region.



On the basis of geography, the market of Infusion Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Infusion Pumps, the sub-segment i.e. Large Volume Infusion Pumps will boost the Infusion Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Infusion Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Accessories and Consumables, the sub-segment i.e. Infusion Sets will boost the Infusion Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological Advancements in Infusion Devices

Market Growth Drivers:
Increasing Aging Population and High Adoption due to Rising Number of Chronic Diseases

Challenges:
Issues Related to Reimbursement Policies

Restraints:
Growing Risk to Patient Safety and Occurrence of Mistakes while using Infusion Devices

Opportunities:
increase in application areas of infusion therapy such as Rheumatoid Arthritis, Crohn’s Disease, Immune deficiencies, Hemophilia, and Multiple Sclerosis

Market Leaders and their expansionary development strategies
In June 2021-Leading health and well-being company Humana Inc. has announced that it has signed a definitive agreement to acquire One Homecare Solutions (“one home”) from WayPoint Capital Partners (WayPoint), the private equity affiliate of a New York-based family investment office.
On August 23, 2021,the National Home Infusion Association (NHIA) lauded the introduction of bipartisan legislation in the U.S. House of Representatives to improve home infusion access in the Medicare program, adding bicameral support for identical legislation introduced in the Senate earlier this month. The Preserving Patient Access to Home Infusion Act (H.R. 5067) — introduced in the House by Reps. Terri Sewell (D-AL), Debbie Dingell (D-MI), Fred Upton (R-MI), and Vern Buchannan (R-FL) — would ensure patients with serious viral and fungal infections, heart failure, immune diseases, cancer, and other conditions can receive intravenous (IV) medications they need while at home. Companion legislation (S. 2652) was introduced in the Senate on August 5th by Sens. Mark Warner (D-VA) and Tim Scott (R-SC).
On December 13, 2016, the 21st Century Cures Act (the Cures Act) was enacted into law. Section 5012 of this new law amended sections 1861(s)(2) and 1861(iii) of the Act, and established a new Medicare home infusion therapy benefit. The Medicare home infusion therapy benefit is for coverage of home infusion therapy-associated professional services for certain drugs and biologicals administered intravenously, or subcutaneously through a pump that is an item of DME, effective January 1, 2021. Section 1861(iii)(2) of the Act defines home infusion therapy to include the following items and services: the professional services (including nursing services), furnished in accordance with the plan, training, and education (not otherwise included in the payment for the DME), remote monitoring, and other monitoring services for the provision of home infusion therapy furnished by a qualified home infusion therapy supplier in the patient’s home.

Key Target Audience
Government Regulatory Bodies, Government Research Organisation, Government Research Organisation, Private Research Organisation and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Intravenous Set
  • Needleless Catheter
  • Infusion Pump
By Application
  • Chemotherapy
  • Diabetes
  • Hydration Therapy
  • Inotropic Therapy
  • Pain Management
  • HIV
  • Post-Transplant Therapies
  • Total Parenteral Nutrition
  • Hemophilia
  • Others
By Infusion Pumps
  • Large Volume Infusion Pumps
  • Syringe Infusion Pumps
  • Patient-Controlled Analgesia Infusion Pumps
  • Ambulatory Infusion Pumps
  • Chemotherapy Infusion Pumps
  • Disposable Infusion Pumps
  • Enteral Infusion Pumps
  • Insulin Infusion Pumps
  • Implantable Infusion Pumps

By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Home Care
  • Others

By Accessories and Consumables
  • Infusion Sets
  • I.V Sets
  • Docking Stations
  • Needleless Connectors
  • Pump Reservoirs/Cartridges
  • Valves and Filters
  • Wireless Connectivity
  • Barcode Readers
  • Infusion Data Management/Analysis Software

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Aging Population
      • 3.2.2. High Adoption due to Rising Number of Chronic Diseases
    • 3.3. Market Challenges
      • 3.3.1. Issues Related to Reimbursement Policies
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Infusion Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Infusion Therapy, by Type, Application, Infusion Pumps, End User, Accessories and Consumables and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Infusion Therapy (Value)
      • 5.2.1. Global Infusion Therapy by: Type (Value)
        • 5.2.1.1. Intravenous Set
        • 5.2.1.2. Needleless Catheter
        • 5.2.1.3. Infusion Pump
      • 5.2.2. Global Infusion Therapy by: Application (Value)
        • 5.2.2.1. Chemotherapy
        • 5.2.2.2. Diabetes
        • 5.2.2.3. Hydration Therapy
        • 5.2.2.4. Inotropic Therapy
        • 5.2.2.5. Pain Management
        • 5.2.2.6. HIV
        • 5.2.2.7. Post-Transplant Therapies
        • 5.2.2.8. Total Parenteral Nutrition
        • 5.2.2.9. Hemophilia
        • 5.2.2.10. Others
      • 5.2.3. Global Infusion Therapy by: Infusion Pumps (Value)
        • 5.2.3.1. Large Volume Infusion Pumps
        • 5.2.3.2. Syringe Infusion Pumps
        • 5.2.3.3. Patient-Controlled Analgesia Infusion Pumps
        • 5.2.3.4. Ambulatory Infusion Pumps
        • 5.2.3.5. Chemotherapy Infusion Pumps
        • 5.2.3.6. Disposable Infusion Pumps
        • 5.2.3.7. Enteral Infusion Pumps
        • 5.2.3.8. Insulin Infusion Pumps
        • 5.2.3.9. Implantable Infusion Pumps
      • 5.2.4. Global Infusion Therapy by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Ambulatory Surgical Centers
        • 5.2.4.3. Specialty Clinics
        • 5.2.4.4. Home Care
        • 5.2.4.5. Others
      • 5.2.5. Global Infusion Therapy by: Accessories and Consumables (Value)
        • 5.2.5.1. Infusion Sets
        • 5.2.5.2. I.V Sets
        • 5.2.5.3. Docking Stations
        • 5.2.5.4. Needleless Connectors
        • 5.2.5.5. Pump Reservoirs/Cartridges
        • 5.2.5.6. Valves and Filters
        • 5.2.5.7. Wireless Connectivity
        • 5.2.5.8. Barcode Readers
        • 5.2.5.9. Infusion Data Management/Analysis Software
      • 5.2.6. Global Infusion Therapy Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Infusion Therapy (Price)
      • 5.3.1. Global Infusion Therapy by: Type (Price)
  • 6. Infusion Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Gentiva Health Services (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. American Home Patient (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Lincare Holdings, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Apria Healthcare. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ContinuumRx (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BioScrip, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. CareCentrix, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Coram LLC (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Medical Services of America, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cleveland Clinic (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Infusion Therapy Sale, by Type, Application, Infusion Pumps, End User, Accessories and Consumables and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Infusion Therapy (Value)
      • 7.2.1. Global Infusion Therapy by: Type (Value)
        • 7.2.1.1. Intravenous Set
        • 7.2.1.2. Needleless Catheter
        • 7.2.1.3. Infusion Pump
      • 7.2.2. Global Infusion Therapy by: Application (Value)
        • 7.2.2.1. Chemotherapy
        • 7.2.2.2. Diabetes
        • 7.2.2.3. Hydration Therapy
        • 7.2.2.4. Inotropic Therapy
        • 7.2.2.5. Pain Management
        • 7.2.2.6. HIV
        • 7.2.2.7. Post-Transplant Therapies
        • 7.2.2.8. Total Parenteral Nutrition
        • 7.2.2.9. Hemophilia
        • 7.2.2.10. Others
      • 7.2.3. Global Infusion Therapy by: Infusion Pumps (Value)
        • 7.2.3.1. Large Volume Infusion Pumps
        • 7.2.3.2. Syringe Infusion Pumps
        • 7.2.3.3. Patient-Controlled Analgesia Infusion Pumps
        • 7.2.3.4. Ambulatory Infusion Pumps
        • 7.2.3.5. Chemotherapy Infusion Pumps
        • 7.2.3.6. Disposable Infusion Pumps
        • 7.2.3.7. Enteral Infusion Pumps
        • 7.2.3.8. Insulin Infusion Pumps
        • 7.2.3.9. Implantable Infusion Pumps
      • 7.2.4. Global Infusion Therapy by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Ambulatory Surgical Centers
        • 7.2.4.3. Specialty Clinics
        • 7.2.4.4. Home Care
        • 7.2.4.5. Others
      • 7.2.5. Global Infusion Therapy by: Accessories and Consumables (Value)
        • 7.2.5.1. Infusion Sets
        • 7.2.5.2. I.V Sets
        • 7.2.5.3. Docking Stations
        • 7.2.5.4. Needleless Connectors
        • 7.2.5.5. Pump Reservoirs/Cartridges
        • 7.2.5.6. Valves and Filters
        • 7.2.5.7. Wireless Connectivity
        • 7.2.5.8. Barcode Readers
        • 7.2.5.9. Infusion Data Management/Analysis Software
      • 7.2.6. Global Infusion Therapy Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Infusion Therapy (Price)
      • 7.3.1. Global Infusion Therapy by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Infusion Therapy: by Type(USD Million)
  • Table 2. Infusion Therapy Intravenous Set , by Region USD Million (2018-2023)
  • Table 3. Infusion Therapy Needleless Catheter , by Region USD Million (2018-2023)
  • Table 4. Infusion Therapy Infusion Pump , by Region USD Million (2018-2023)
  • Table 5. Infusion Therapy: by Application(USD Million)
  • Table 6. Infusion Therapy Chemotherapy , by Region USD Million (2018-2023)
  • Table 7. Infusion Therapy Diabetes , by Region USD Million (2018-2023)
  • Table 8. Infusion Therapy Hydration Therapy , by Region USD Million (2018-2023)
  • Table 9. Infusion Therapy Inotropic Therapy , by Region USD Million (2018-2023)
  • Table 10. Infusion Therapy Pain Management , by Region USD Million (2018-2023)
  • Table 11. Infusion Therapy HIV , by Region USD Million (2018-2023)
  • Table 12. Infusion Therapy Post-Transplant Therapies , by Region USD Million (2018-2023)
  • Table 13. Infusion Therapy Total Parenteral Nutrition , by Region USD Million (2018-2023)
  • Table 14. Infusion Therapy Hemophilia , by Region USD Million (2018-2023)
  • Table 15. Infusion Therapy Others , by Region USD Million (2018-2023)
  • Table 16. Infusion Therapy: by Infusion Pumps(USD Million)
  • Table 17. Infusion Therapy Large Volume Infusion Pumps , by Region USD Million (2018-2023)
  • Table 18. Infusion Therapy Syringe Infusion Pumps , by Region USD Million (2018-2023)
  • Table 19. Infusion Therapy Patient-Controlled Analgesia Infusion Pumps , by Region USD Million (2018-2023)
  • Table 20. Infusion Therapy Ambulatory Infusion Pumps , by Region USD Million (2018-2023)
  • Table 21. Infusion Therapy Chemotherapy Infusion Pumps , by Region USD Million (2018-2023)
  • Table 22. Infusion Therapy Disposable Infusion Pumps , by Region USD Million (2018-2023)
  • Table 23. Infusion Therapy Enteral Infusion Pumps , by Region USD Million (2018-2023)
  • Table 24. Infusion Therapy Insulin Infusion Pumps , by Region USD Million (2018-2023)
  • Table 25. Infusion Therapy Implantable Infusion Pumps , by Region USD Million (2018-2023)
  • Table 26. Infusion Therapy: by End User(USD Million)
  • Table 27. Infusion Therapy Hospitals , by Region USD Million (2018-2023)
  • Table 28. Infusion Therapy Ambulatory Surgical Centers , by Region USD Million (2018-2023)
  • Table 29. Infusion Therapy Specialty Clinics , by Region USD Million (2018-2023)
  • Table 30. Infusion Therapy Home Care , by Region USD Million (2018-2023)
  • Table 31. Infusion Therapy Others , by Region USD Million (2018-2023)
  • Table 32. Infusion Therapy: by Accessories and Consumables(USD Million)
  • Table 33. Infusion Therapy Infusion Sets , by Region USD Million (2018-2023)
  • Table 34. Infusion Therapy I.V Sets , by Region USD Million (2018-2023)
  • Table 35. Infusion Therapy Docking Stations , by Region USD Million (2018-2023)
  • Table 36. Infusion Therapy Needleless Connectors , by Region USD Million (2018-2023)
  • Table 37. Infusion Therapy Pump Reservoirs/Cartridges , by Region USD Million (2018-2023)
  • Table 38. Infusion Therapy Valves and Filters , by Region USD Million (2018-2023)
  • Table 39. Infusion Therapy Wireless Connectivity , by Region USD Million (2018-2023)
  • Table 40. Infusion Therapy Barcode Readers , by Region USD Million (2018-2023)
  • Table 41. Infusion Therapy Infusion Data Management/Analysis Software , by Region USD Million (2018-2023)
  • Table 42. South America Infusion Therapy, by Country USD Million (2018-2023)
  • Table 43. South America Infusion Therapy, by Type USD Million (2018-2023)
  • Table 44. South America Infusion Therapy, by Application USD Million (2018-2023)
  • Table 45. South America Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 46. South America Infusion Therapy, by End User USD Million (2018-2023)
  • Table 47. South America Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 48. Brazil Infusion Therapy, by Type USD Million (2018-2023)
  • Table 49. Brazil Infusion Therapy, by Application USD Million (2018-2023)
  • Table 50. Brazil Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 51. Brazil Infusion Therapy, by End User USD Million (2018-2023)
  • Table 52. Brazil Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 53. Argentina Infusion Therapy, by Type USD Million (2018-2023)
  • Table 54. Argentina Infusion Therapy, by Application USD Million (2018-2023)
  • Table 55. Argentina Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 56. Argentina Infusion Therapy, by End User USD Million (2018-2023)
  • Table 57. Argentina Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 58. Rest of South America Infusion Therapy, by Type USD Million (2018-2023)
  • Table 59. Rest of South America Infusion Therapy, by Application USD Million (2018-2023)
  • Table 60. Rest of South America Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 61. Rest of South America Infusion Therapy, by End User USD Million (2018-2023)
  • Table 62. Rest of South America Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 63. Asia Pacific Infusion Therapy, by Country USD Million (2018-2023)
  • Table 64. Asia Pacific Infusion Therapy, by Type USD Million (2018-2023)
  • Table 65. Asia Pacific Infusion Therapy, by Application USD Million (2018-2023)
  • Table 66. Asia Pacific Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 67. Asia Pacific Infusion Therapy, by End User USD Million (2018-2023)
  • Table 68. Asia Pacific Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 69. China Infusion Therapy, by Type USD Million (2018-2023)
  • Table 70. China Infusion Therapy, by Application USD Million (2018-2023)
  • Table 71. China Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 72. China Infusion Therapy, by End User USD Million (2018-2023)
  • Table 73. China Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 74. Japan Infusion Therapy, by Type USD Million (2018-2023)
  • Table 75. Japan Infusion Therapy, by Application USD Million (2018-2023)
  • Table 76. Japan Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 77. Japan Infusion Therapy, by End User USD Million (2018-2023)
  • Table 78. Japan Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 79. India Infusion Therapy, by Type USD Million (2018-2023)
  • Table 80. India Infusion Therapy, by Application USD Million (2018-2023)
  • Table 81. India Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 82. India Infusion Therapy, by End User USD Million (2018-2023)
  • Table 83. India Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 84. South Korea Infusion Therapy, by Type USD Million (2018-2023)
  • Table 85. South Korea Infusion Therapy, by Application USD Million (2018-2023)
  • Table 86. South Korea Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 87. South Korea Infusion Therapy, by End User USD Million (2018-2023)
  • Table 88. South Korea Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 89. Taiwan Infusion Therapy, by Type USD Million (2018-2023)
  • Table 90. Taiwan Infusion Therapy, by Application USD Million (2018-2023)
  • Table 91. Taiwan Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 92. Taiwan Infusion Therapy, by End User USD Million (2018-2023)
  • Table 93. Taiwan Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 94. Australia Infusion Therapy, by Type USD Million (2018-2023)
  • Table 95. Australia Infusion Therapy, by Application USD Million (2018-2023)
  • Table 96. Australia Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 97. Australia Infusion Therapy, by End User USD Million (2018-2023)
  • Table 98. Australia Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 99. Rest of Asia-Pacific Infusion Therapy, by Type USD Million (2018-2023)
  • Table 100. Rest of Asia-Pacific Infusion Therapy, by Application USD Million (2018-2023)
  • Table 101. Rest of Asia-Pacific Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 102. Rest of Asia-Pacific Infusion Therapy, by End User USD Million (2018-2023)
  • Table 103. Rest of Asia-Pacific Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 104. Europe Infusion Therapy, by Country USD Million (2018-2023)
  • Table 105. Europe Infusion Therapy, by Type USD Million (2018-2023)
  • Table 106. Europe Infusion Therapy, by Application USD Million (2018-2023)
  • Table 107. Europe Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 108. Europe Infusion Therapy, by End User USD Million (2018-2023)
  • Table 109. Europe Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 110. Germany Infusion Therapy, by Type USD Million (2018-2023)
  • Table 111. Germany Infusion Therapy, by Application USD Million (2018-2023)
  • Table 112. Germany Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 113. Germany Infusion Therapy, by End User USD Million (2018-2023)
  • Table 114. Germany Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 115. France Infusion Therapy, by Type USD Million (2018-2023)
  • Table 116. France Infusion Therapy, by Application USD Million (2018-2023)
  • Table 117. France Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 118. France Infusion Therapy, by End User USD Million (2018-2023)
  • Table 119. France Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 120. Italy Infusion Therapy, by Type USD Million (2018-2023)
  • Table 121. Italy Infusion Therapy, by Application USD Million (2018-2023)
  • Table 122. Italy Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 123. Italy Infusion Therapy, by End User USD Million (2018-2023)
  • Table 124. Italy Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 125. United Kingdom Infusion Therapy, by Type USD Million (2018-2023)
  • Table 126. United Kingdom Infusion Therapy, by Application USD Million (2018-2023)
  • Table 127. United Kingdom Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 128. United Kingdom Infusion Therapy, by End User USD Million (2018-2023)
  • Table 129. United Kingdom Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 130. Netherlands Infusion Therapy, by Type USD Million (2018-2023)
  • Table 131. Netherlands Infusion Therapy, by Application USD Million (2018-2023)
  • Table 132. Netherlands Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 133. Netherlands Infusion Therapy, by End User USD Million (2018-2023)
  • Table 134. Netherlands Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 135. Rest of Europe Infusion Therapy, by Type USD Million (2018-2023)
  • Table 136. Rest of Europe Infusion Therapy, by Application USD Million (2018-2023)
  • Table 137. Rest of Europe Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 138. Rest of Europe Infusion Therapy, by End User USD Million (2018-2023)
  • Table 139. Rest of Europe Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 140. MEA Infusion Therapy, by Country USD Million (2018-2023)
  • Table 141. MEA Infusion Therapy, by Type USD Million (2018-2023)
  • Table 142. MEA Infusion Therapy, by Application USD Million (2018-2023)
  • Table 143. MEA Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 144. MEA Infusion Therapy, by End User USD Million (2018-2023)
  • Table 145. MEA Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 146. Middle East Infusion Therapy, by Type USD Million (2018-2023)
  • Table 147. Middle East Infusion Therapy, by Application USD Million (2018-2023)
  • Table 148. Middle East Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 149. Middle East Infusion Therapy, by End User USD Million (2018-2023)
  • Table 150. Middle East Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 151. Africa Infusion Therapy, by Type USD Million (2018-2023)
  • Table 152. Africa Infusion Therapy, by Application USD Million (2018-2023)
  • Table 153. Africa Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 154. Africa Infusion Therapy, by End User USD Million (2018-2023)
  • Table 155. Africa Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 156. North America Infusion Therapy, by Country USD Million (2018-2023)
  • Table 157. North America Infusion Therapy, by Type USD Million (2018-2023)
  • Table 158. North America Infusion Therapy, by Application USD Million (2018-2023)
  • Table 159. North America Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 160. North America Infusion Therapy, by End User USD Million (2018-2023)
  • Table 161. North America Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 162. United States Infusion Therapy, by Type USD Million (2018-2023)
  • Table 163. United States Infusion Therapy, by Application USD Million (2018-2023)
  • Table 164. United States Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 165. United States Infusion Therapy, by End User USD Million (2018-2023)
  • Table 166. United States Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 167. Canada Infusion Therapy, by Type USD Million (2018-2023)
  • Table 168. Canada Infusion Therapy, by Application USD Million (2018-2023)
  • Table 169. Canada Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 170. Canada Infusion Therapy, by End User USD Million (2018-2023)
  • Table 171. Canada Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 172. Mexico Infusion Therapy, by Type USD Million (2018-2023)
  • Table 173. Mexico Infusion Therapy, by Application USD Million (2018-2023)
  • Table 174. Mexico Infusion Therapy, by Infusion Pumps USD Million (2018-2023)
  • Table 175. Mexico Infusion Therapy, by End User USD Million (2018-2023)
  • Table 176. Mexico Infusion Therapy, by Accessories and Consumables USD Million (2018-2023)
  • Table 177. Infusion Therapy: by Type(USD/Units)
  • Table 178. Company Basic Information, Sales Area and Its Competitors
  • Table 179. Company Basic Information, Sales Area and Its Competitors
  • Table 180. Company Basic Information, Sales Area and Its Competitors
  • Table 181. Company Basic Information, Sales Area and Its Competitors
  • Table 182. Company Basic Information, Sales Area and Its Competitors
  • Table 183. Company Basic Information, Sales Area and Its Competitors
  • Table 184. Company Basic Information, Sales Area and Its Competitors
  • Table 185. Company Basic Information, Sales Area and Its Competitors
  • Table 186. Company Basic Information, Sales Area and Its Competitors
  • Table 187. Company Basic Information, Sales Area and Its Competitors
  • Table 188. Infusion Therapy: by Type(USD Million)
  • Table 189. Infusion Therapy Intravenous Set , by Region USD Million (2025-2030)
  • Table 190. Infusion Therapy Needleless Catheter , by Region USD Million (2025-2030)
  • Table 191. Infusion Therapy Infusion Pump , by Region USD Million (2025-2030)
  • Table 192. Infusion Therapy: by Application(USD Million)
  • Table 193. Infusion Therapy Chemotherapy , by Region USD Million (2025-2030)
  • Table 194. Infusion Therapy Diabetes , by Region USD Million (2025-2030)
  • Table 195. Infusion Therapy Hydration Therapy , by Region USD Million (2025-2030)
  • Table 196. Infusion Therapy Inotropic Therapy , by Region USD Million (2025-2030)
  • Table 197. Infusion Therapy Pain Management , by Region USD Million (2025-2030)
  • Table 198. Infusion Therapy HIV , by Region USD Million (2025-2030)
  • Table 199. Infusion Therapy Post-Transplant Therapies , by Region USD Million (2025-2030)
  • Table 200. Infusion Therapy Total Parenteral Nutrition , by Region USD Million (2025-2030)
  • Table 201. Infusion Therapy Hemophilia , by Region USD Million (2025-2030)
  • Table 202. Infusion Therapy Others , by Region USD Million (2025-2030)
  • Table 203. Infusion Therapy: by Infusion Pumps(USD Million)
  • Table 204. Infusion Therapy Large Volume Infusion Pumps , by Region USD Million (2025-2030)
  • Table 205. Infusion Therapy Syringe Infusion Pumps , by Region USD Million (2025-2030)
  • Table 206. Infusion Therapy Patient-Controlled Analgesia Infusion Pumps , by Region USD Million (2025-2030)
  • Table 207. Infusion Therapy Ambulatory Infusion Pumps , by Region USD Million (2025-2030)
  • Table 208. Infusion Therapy Chemotherapy Infusion Pumps , by Region USD Million (2025-2030)
  • Table 209. Infusion Therapy Disposable Infusion Pumps , by Region USD Million (2025-2030)
  • Table 210. Infusion Therapy Enteral Infusion Pumps , by Region USD Million (2025-2030)
  • Table 211. Infusion Therapy Insulin Infusion Pumps , by Region USD Million (2025-2030)
  • Table 212. Infusion Therapy Implantable Infusion Pumps , by Region USD Million (2025-2030)
  • Table 213. Infusion Therapy: by End User(USD Million)
  • Table 214. Infusion Therapy Hospitals , by Region USD Million (2025-2030)
  • Table 215. Infusion Therapy Ambulatory Surgical Centers , by Region USD Million (2025-2030)
  • Table 216. Infusion Therapy Specialty Clinics , by Region USD Million (2025-2030)
  • Table 217. Infusion Therapy Home Care , by Region USD Million (2025-2030)
  • Table 218. Infusion Therapy Others , by Region USD Million (2025-2030)
  • Table 219. Infusion Therapy: by Accessories and Consumables(USD Million)
  • Table 220. Infusion Therapy Infusion Sets , by Region USD Million (2025-2030)
  • Table 221. Infusion Therapy I.V Sets , by Region USD Million (2025-2030)
  • Table 222. Infusion Therapy Docking Stations , by Region USD Million (2025-2030)
  • Table 223. Infusion Therapy Needleless Connectors , by Region USD Million (2025-2030)
  • Table 224. Infusion Therapy Pump Reservoirs/Cartridges , by Region USD Million (2025-2030)
  • Table 225. Infusion Therapy Valves and Filters , by Region USD Million (2025-2030)
  • Table 226. Infusion Therapy Wireless Connectivity , by Region USD Million (2025-2030)
  • Table 227. Infusion Therapy Barcode Readers , by Region USD Million (2025-2030)
  • Table 228. Infusion Therapy Infusion Data Management/Analysis Software , by Region USD Million (2025-2030)
  • Table 229. South America Infusion Therapy, by Country USD Million (2025-2030)
  • Table 230. South America Infusion Therapy, by Type USD Million (2025-2030)
  • Table 231. South America Infusion Therapy, by Application USD Million (2025-2030)
  • Table 232. South America Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 233. South America Infusion Therapy, by End User USD Million (2025-2030)
  • Table 234. South America Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 235. Brazil Infusion Therapy, by Type USD Million (2025-2030)
  • Table 236. Brazil Infusion Therapy, by Application USD Million (2025-2030)
  • Table 237. Brazil Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 238. Brazil Infusion Therapy, by End User USD Million (2025-2030)
  • Table 239. Brazil Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 240. Argentina Infusion Therapy, by Type USD Million (2025-2030)
  • Table 241. Argentina Infusion Therapy, by Application USD Million (2025-2030)
  • Table 242. Argentina Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 243. Argentina Infusion Therapy, by End User USD Million (2025-2030)
  • Table 244. Argentina Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 245. Rest of South America Infusion Therapy, by Type USD Million (2025-2030)
  • Table 246. Rest of South America Infusion Therapy, by Application USD Million (2025-2030)
  • Table 247. Rest of South America Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 248. Rest of South America Infusion Therapy, by End User USD Million (2025-2030)
  • Table 249. Rest of South America Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 250. Asia Pacific Infusion Therapy, by Country USD Million (2025-2030)
  • Table 251. Asia Pacific Infusion Therapy, by Type USD Million (2025-2030)
  • Table 252. Asia Pacific Infusion Therapy, by Application USD Million (2025-2030)
  • Table 253. Asia Pacific Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 254. Asia Pacific Infusion Therapy, by End User USD Million (2025-2030)
  • Table 255. Asia Pacific Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 256. China Infusion Therapy, by Type USD Million (2025-2030)
  • Table 257. China Infusion Therapy, by Application USD Million (2025-2030)
  • Table 258. China Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 259. China Infusion Therapy, by End User USD Million (2025-2030)
  • Table 260. China Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 261. Japan Infusion Therapy, by Type USD Million (2025-2030)
  • Table 262. Japan Infusion Therapy, by Application USD Million (2025-2030)
  • Table 263. Japan Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 264. Japan Infusion Therapy, by End User USD Million (2025-2030)
  • Table 265. Japan Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 266. India Infusion Therapy, by Type USD Million (2025-2030)
  • Table 267. India Infusion Therapy, by Application USD Million (2025-2030)
  • Table 268. India Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 269. India Infusion Therapy, by End User USD Million (2025-2030)
  • Table 270. India Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 271. South Korea Infusion Therapy, by Type USD Million (2025-2030)
  • Table 272. South Korea Infusion Therapy, by Application USD Million (2025-2030)
  • Table 273. South Korea Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 274. South Korea Infusion Therapy, by End User USD Million (2025-2030)
  • Table 275. South Korea Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 276. Taiwan Infusion Therapy, by Type USD Million (2025-2030)
  • Table 277. Taiwan Infusion Therapy, by Application USD Million (2025-2030)
  • Table 278. Taiwan Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 279. Taiwan Infusion Therapy, by End User USD Million (2025-2030)
  • Table 280. Taiwan Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 281. Australia Infusion Therapy, by Type USD Million (2025-2030)
  • Table 282. Australia Infusion Therapy, by Application USD Million (2025-2030)
  • Table 283. Australia Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 284. Australia Infusion Therapy, by End User USD Million (2025-2030)
  • Table 285. Australia Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 286. Rest of Asia-Pacific Infusion Therapy, by Type USD Million (2025-2030)
  • Table 287. Rest of Asia-Pacific Infusion Therapy, by Application USD Million (2025-2030)
  • Table 288. Rest of Asia-Pacific Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 289. Rest of Asia-Pacific Infusion Therapy, by End User USD Million (2025-2030)
  • Table 290. Rest of Asia-Pacific Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 291. Europe Infusion Therapy, by Country USD Million (2025-2030)
  • Table 292. Europe Infusion Therapy, by Type USD Million (2025-2030)
  • Table 293. Europe Infusion Therapy, by Application USD Million (2025-2030)
  • Table 294. Europe Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 295. Europe Infusion Therapy, by End User USD Million (2025-2030)
  • Table 296. Europe Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 297. Germany Infusion Therapy, by Type USD Million (2025-2030)
  • Table 298. Germany Infusion Therapy, by Application USD Million (2025-2030)
  • Table 299. Germany Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 300. Germany Infusion Therapy, by End User USD Million (2025-2030)
  • Table 301. Germany Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 302. France Infusion Therapy, by Type USD Million (2025-2030)
  • Table 303. France Infusion Therapy, by Application USD Million (2025-2030)
  • Table 304. France Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 305. France Infusion Therapy, by End User USD Million (2025-2030)
  • Table 306. France Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 307. Italy Infusion Therapy, by Type USD Million (2025-2030)
  • Table 308. Italy Infusion Therapy, by Application USD Million (2025-2030)
  • Table 309. Italy Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 310. Italy Infusion Therapy, by End User USD Million (2025-2030)
  • Table 311. Italy Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 312. United Kingdom Infusion Therapy, by Type USD Million (2025-2030)
  • Table 313. United Kingdom Infusion Therapy, by Application USD Million (2025-2030)
  • Table 314. United Kingdom Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 315. United Kingdom Infusion Therapy, by End User USD Million (2025-2030)
  • Table 316. United Kingdom Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 317. Netherlands Infusion Therapy, by Type USD Million (2025-2030)
  • Table 318. Netherlands Infusion Therapy, by Application USD Million (2025-2030)
  • Table 319. Netherlands Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 320. Netherlands Infusion Therapy, by End User USD Million (2025-2030)
  • Table 321. Netherlands Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 322. Rest of Europe Infusion Therapy, by Type USD Million (2025-2030)
  • Table 323. Rest of Europe Infusion Therapy, by Application USD Million (2025-2030)
  • Table 324. Rest of Europe Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 325. Rest of Europe Infusion Therapy, by End User USD Million (2025-2030)
  • Table 326. Rest of Europe Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 327. MEA Infusion Therapy, by Country USD Million (2025-2030)
  • Table 328. MEA Infusion Therapy, by Type USD Million (2025-2030)
  • Table 329. MEA Infusion Therapy, by Application USD Million (2025-2030)
  • Table 330. MEA Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 331. MEA Infusion Therapy, by End User USD Million (2025-2030)
  • Table 332. MEA Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 333. Middle East Infusion Therapy, by Type USD Million (2025-2030)
  • Table 334. Middle East Infusion Therapy, by Application USD Million (2025-2030)
  • Table 335. Middle East Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 336. Middle East Infusion Therapy, by End User USD Million (2025-2030)
  • Table 337. Middle East Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 338. Africa Infusion Therapy, by Type USD Million (2025-2030)
  • Table 339. Africa Infusion Therapy, by Application USD Million (2025-2030)
  • Table 340. Africa Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 341. Africa Infusion Therapy, by End User USD Million (2025-2030)
  • Table 342. Africa Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 343. North America Infusion Therapy, by Country USD Million (2025-2030)
  • Table 344. North America Infusion Therapy, by Type USD Million (2025-2030)
  • Table 345. North America Infusion Therapy, by Application USD Million (2025-2030)
  • Table 346. North America Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 347. North America Infusion Therapy, by End User USD Million (2025-2030)
  • Table 348. North America Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 349. United States Infusion Therapy, by Type USD Million (2025-2030)
  • Table 350. United States Infusion Therapy, by Application USD Million (2025-2030)
  • Table 351. United States Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 352. United States Infusion Therapy, by End User USD Million (2025-2030)
  • Table 353. United States Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 354. Canada Infusion Therapy, by Type USD Million (2025-2030)
  • Table 355. Canada Infusion Therapy, by Application USD Million (2025-2030)
  • Table 356. Canada Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 357. Canada Infusion Therapy, by End User USD Million (2025-2030)
  • Table 358. Canada Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 359. Mexico Infusion Therapy, by Type USD Million (2025-2030)
  • Table 360. Mexico Infusion Therapy, by Application USD Million (2025-2030)
  • Table 361. Mexico Infusion Therapy, by Infusion Pumps USD Million (2025-2030)
  • Table 362. Mexico Infusion Therapy, by End User USD Million (2025-2030)
  • Table 363. Mexico Infusion Therapy, by Accessories and Consumables USD Million (2025-2030)
  • Table 364. Infusion Therapy: by Type(USD/Units)
  • Table 365. Research Programs/Design for This Report
  • Table 366. Key Data Information from Secondary Sources
  • Table 367. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Infusion Therapy: by Type USD Million (2018-2023)
  • Figure 5. Global Infusion Therapy: by Application USD Million (2018-2023)
  • Figure 6. Global Infusion Therapy: by Infusion Pumps USD Million (2018-2023)
  • Figure 7. Global Infusion Therapy: by End User USD Million (2018-2023)
  • Figure 8. Global Infusion Therapy: by Accessories and Consumables USD Million (2018-2023)
  • Figure 9. South America Infusion Therapy Share (%), by Country
  • Figure 10. Asia Pacific Infusion Therapy Share (%), by Country
  • Figure 11. Europe Infusion Therapy Share (%), by Country
  • Figure 12. MEA Infusion Therapy Share (%), by Country
  • Figure 13. North America Infusion Therapy Share (%), by Country
  • Figure 14. Global Infusion Therapy: by Type USD/Units (2018-2023)
  • Figure 15. Global Infusion Therapy share by Players 2023 (%)
  • Figure 16. Global Infusion Therapy share by Players (Top 3) 2023(%)
  • Figure 17. Global Infusion Therapy share by Players (Top 5) 2023(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Gentiva Health Services (United States) Revenue, Net Income and Gross profit
  • Figure 20. Gentiva Health Services (United States) Revenue: by Geography 2023
  • Figure 21. American Home Patient (United States) Revenue, Net Income and Gross profit
  • Figure 22. American Home Patient (United States) Revenue: by Geography 2023
  • Figure 23. Lincare Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Lincare Holdings, Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Apria Healthcare. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Apria Healthcare. (United States) Revenue: by Geography 2023
  • Figure 27. ContinuumRx (United States) Revenue, Net Income and Gross profit
  • Figure 28. ContinuumRx (United States) Revenue: by Geography 2023
  • Figure 29. BioScrip, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. BioScrip, Inc. (United States) Revenue: by Geography 2023
  • Figure 31. CareCentrix, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. CareCentrix, Inc. (United States) Revenue: by Geography 2023
  • Figure 33. Coram LLC (United States) Revenue, Net Income and Gross profit
  • Figure 34. Coram LLC (United States) Revenue: by Geography 2023
  • Figure 35. Medical Services of America, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Medical Services of America, Inc. (United States) Revenue: by Geography 2023
  • Figure 37. Cleveland Clinic (United States) Revenue, Net Income and Gross profit
  • Figure 38. Cleveland Clinic (United States) Revenue: by Geography 2023
  • Figure 39. Global Infusion Therapy: by Type USD Million (2025-2030)
  • Figure 40. Global Infusion Therapy: by Application USD Million (2025-2030)
  • Figure 41. Global Infusion Therapy: by Infusion Pumps USD Million (2025-2030)
  • Figure 42. Global Infusion Therapy: by End User USD Million (2025-2030)
  • Figure 43. Global Infusion Therapy: by Accessories and Consumables USD Million (2025-2030)
  • Figure 44. South America Infusion Therapy Share (%), by Country
  • Figure 45. Asia Pacific Infusion Therapy Share (%), by Country
  • Figure 46. Europe Infusion Therapy Share (%), by Country
  • Figure 47. MEA Infusion Therapy Share (%), by Country
  • Figure 48. North America Infusion Therapy Share (%), by Country
  • Figure 49. Global Infusion Therapy: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Gentiva Health Services (United States)
  • American Home Patient (United States)
  • Lincare Holdings, Inc. (United States)
  • Apria Healthcare. (United States)
  • ContinuumRx (United States)
  • BioScrip, Inc. (United States)
  • CareCentrix, Inc. (United States)
  • Coram LLC (United States)
  • Medical Services of America, Inc. (United States)
  • Cleveland Clinic (United States)
Additional players considered in the study are as follows:
Option Care Enterprises, Inc. (United States) , Allina Health (United States) , ICU Medical, Inc. (United States) , Hospira, Inc.(United States) , B. Braun Melsungen AG (Germany) , Caesarea Medical Electronics (Israel) , JMSCo. Ltd., Baxter (United States) , Novartis (Switzerland) , Roche Diagnostics (Switzerland)
Select User Access Type

Key Highlights of Report


Jan 2024 237 Pages 82 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Infusion Therapy Market Quantitative research analysis
Global Infusion Therapy Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Gentiva Health Services (United States), American Home Patient (United States), Lincare Holdings, Inc. (United States), Apria Healthcare. (United States), ContinuumRx (United States), BioScrip, Inc. (United States), CareCentrix, Inc. (United States), Coram LLC (United States), Medical Services of America, Inc. (United States) and Cleveland Clinic (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological Advancements in Infusion Devices" is seen as one of major influencing trends for Infusion Therapy Market during projected period 2023-2030.
The Infusion Therapy market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Infusion Therapy Market Report?

Have a Query? Click Here

Other Related Reports

Hantavirus Comprehensive Study by Type (Sin Nombre, Black Creek Hantavirus, Seoul Virus, New York Hantavirus), Application (Hospitals, Clinics, Intensive Care Unit), Treatment (Mechanical Ventilation...
$ 3650
Edema Clinical Comprehensive Study by Type (Systematic Edema Clinical {Cardiac Disease, Hepatic Disease, Renal Disease, Others}, Local Edema Clinical {Cellulitis, Chronic Venous Insufficiency, Others...
$ 3750
Stereotactic Radiosurgery Comprehensive Study by Application (Brain Tumors, Arteriovenous Malformations (AVMs), Trigeminal Neuralgia, Tremor, Others), End-User (Hospitals, Clinics, Ambulatory Surgery...
$ 3650
Hormone Replacement Therapeutics Comprehensive Study by Type (Estrogen Hormone, Growth Hormone, Thyroid Hormone, Testosterone Hormone), Application (Menopause, Hypothyroidism, Growth Hormone Deficien...
$ 3750
Bone Cancer Treatment Comprehensive Study by Type (Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Dr...
$ 3800
Hemoglobinopathies Comprehensive Study by Type (Thalassemia (Alpha Thalassemia, Beta Thalassemia), Sickle Cell Disease, Other Hb Variants Diseases), Application (Blood Testing, Genetic Testing, Pre-I...
$ 3750